Shares of eHealth (EHTH) is expected to continue the bull run backed by solid fundamentals and initiatives to ramp up growth.

Essen, Germany - (NewMediaWire) - March 11, 2019 - Huawei’s 5G outdoor customer-premises equipment (CPE) wins Red Dot Award: Product Design 2019 recently. Huawei's 5G CPE 2.0 won the award for its cutting-edge design concept and unparalleled innovation that is breaking new ground in the development of 5G. Product Design of Red Dot Award is considered as the world's most renowned product design award and is an established symbol of excellent design worldwideHuawei’s 5G outdoor CPE2.0 is designed by Huawei's CPE team in China and the Huawei design team in Munich, Germany, based on the concept of “Ridge”, which symbolize Huawei's dedication to providing optimal 5G experience for users, and Huawei's spirit of continuous self-challenge. The CPE 2.0's unique Ridge design also integrates indoor and outdoor devices, users, and the environment. The top of the indoor unit tilts forwards and faces users, representing its user-friendliness. The outdoor unit faces the base station and presents a neat and elegant appearance to users.The 5G era will see an explosion of data transmission, with a qualitative leap in communication speed and experience requirements. The outdoor design of Huawei's 5G CPE 2.0 enables it to provide stronger signals. The CPE 2.0's high signal strength and computing power allows it to provide data speeds higher than 3.5 Gbit/s, which is dozens of times higher than current home broadband speeds.Huawei's 5G CPE 2.0 is also fully compatible with 4G networks and frequency bands. This allows it to simply and seamlessly replace 4G outdoor CPEs in an extremely simplified manner, with no user installation and maintenance.2019 is the first year for large-scale commercial use of 5G. 5G wireless to the x (WTTx) has been widely recognized as a major 5G application scenario.Huawei's CPE 2.0 was designed with simplified installation and optimal experience in mind. It supports all mainstream 5G frequency bands and meets the requirements for large-scale commercial use of 5G. The CPE 2.0 promotes 5G development and marks a new milestone in the search for ever better means of communication."Huawei started investing in CPE research in 2016—two years before the 3GPP Release 15 specifications that established the standards for 5G New Radio (NR) were frozen," said Yu Jun, Huawei's 5G CPE product director. "Huawei's early investment in 5G CPE research reflects our sense of responsibility for driving forward the development of the entire 5G industry.""Winning the Red Dot Award boosts Huawei's confidence in our mission to continuously develop better products and to bring the best 5G experience to every household," Yu said. The 5G era is here. Huawei is committed to redoubling its efforts and investments in 5G end-to-end product research and development, so as to provide faster and better 5G services to all households and societies.John Leung John.leung@wmglobal.com

Dilution Has Been SuspendedNewport Beach, CA - (NewMediaWire) - March 11, 2019 - M Line Holdings, Inc. (OTC Pink: MLHC; "M Line" or the “Company”) announces that it has negotiated a suspension of dilution with its debt holders. This would not have been possible some weeks ago and we are very pleased that the lenders have recognized that we need to improve shareholder value.We have achieved a great deal over the last 8 months and to those parties not familiar with our growth I have summed it up below:August, 2018We acquired 55% of The Caravel Group, our beverage branding and distribution Company55% of Best Choice Food and Beverage our food and beverage Distribution Company located in Florida and another 20% in September.September, 2018We acquired Best Choice Nuts, Candy and Specialties, Inc., another beverage and food distributor in Florida, and began the process of merging the two Best Choices into one operation.October, 2018We acquired 60% of American Asset Holdings, Inc. the company that builds our “off the grid” growing pods used to grow cannabis and vegetables.We acquired Dimension Beverages, LLC, which owned the Torque® brand of energy drinks. We have since transferred the management of this brand to the Caravel GroupWe announced that we were entering into a joint venture to market the “Rise” brand of CBD products. This is the ONLY transaction we have not closed yet however we expect to do so very shortly.January, 2019We announced that we have acquired the rights to the Larry Caputo brand of imported wines. The first shipments from Italy will be arriving in March 2019 a little behind our original schedule.February, 2019We acquired three operating restaurants/bars, an event center, and 38.5 acres of land in Arizona.March, 2019As mentioned in previous releases, we have major news to be released as soon as possible.Tony Anish, CEO of M Line, commented: “This astonishing growth has not yet been reflected in Shareholder Value, however with Revenues and EBITDA continuing to improve we know this will change. I want to thank our debt lenders for working with us to help improve Shareholder Value.” Tony continued: “To our shareholders, I want to state again, we have NO intention of reversing our stock, but we do intend to be able to start a share buy-back program very soon.”About M Line Holdings, Inc.M Line is a Holding Company. It controls subsidiaries involved in the Beverage Branding and Distribution industry that includes our branded drinks. In addition, M Line controls two subsidiaries in Florida in the Food and Beverage distribution business and M Line has now expanded into the Cannabis Industry with the acquisition of our C-Pod manufacturing business. M Line owns three restaurants and an event center in Arizona and land for development. M Line will continue with its business financing activities while looking for other opportunities in the Beverage, Distribution, hospitality and Cannabis industries as well as other prospects that make sense to management.Safe Harbor and Informational StatementThis press release may contain forward-looking information within the meaning of Section 21E of the Security Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statement of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial conditions or results of operations; (iii): the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends.The words "may", "would", "will", "expect", "estimate", "anticipate", "believe", "intend", and similar expressions and variations thereof are intend to identify forward-looking statements. Investors are cautioned that any such forward-looking statement is not a guarantee of future of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially ...

Atlanta, GA - (NewMediaWire) - March 11, 2019 - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines and immunotherapies using its novel viral vector platform technology, today provided an update on its progress and development programs.David Dodd, GeoVax President and CEO, commented, “We continue to advance GeoVax’s development programs on multiple fronts with an expanding list of world-class government, academic and corporate collaborators, as further described in this update. I am pleased with what the GeoVax team has accomplished during 2018 and so far in 2019, but I also recognize that our constrained capital resources continue to limit our ability to meaningfully advance our products as rapidly as we would like. Going forward, we will continue to evaluate options to secure the capital needed to proceed with our business plan, especially to advance further programs into human clinical testing. We view this as critical to our overall corporate development and enhancement of shareholder value. I remain highly optimistic about the future of our company and I look forward to sharing additional news in the coming months. All of us at GeoVax wish to thank our shareholders for their continued support as GeoVax progresses toward a status of having multiple clinical programs underway, addressing various infectious diseases and cancer indications, having a capital structure that supports continued execution of our strategy and business plan.”A few highlights from 2018 and early 2019 include:Immuno-oncology - A Promising and Expanding Program. We began 2018 with a single program in this area (tumor-associated MUC1 vaccines) supported by two collaborations (University of Pittsburgh and ViaMune) and that work is continuing to expand and advance. During 2018, we added four more collaborations to expand our footprint in this space -- with Vaxeal Holding SA (Cyclin B1 tumor-associated antigen), Emory University (HPV-related head and neck cancers), Virometix AG (also for HPV-related cancers), and Leidos, Inc. (multiple potential cancer targets). We believe immuno-oncology to be important for the future of GeoVax and we intend to vigorously pursue development of these programs. Raising sufficient capital will be key to rapidly advancing in this area.Defense Department Grant - Our First Entrée into the U.S. Government Biodefense System. In September the U.S. Department of Defense (DoD) awarded us a $2.4 million grant to support our Lassa Fever vaccine program. The DoD will also fund testing of our vaccine by U.S. Army scientists at USAMRIID under a separate sub-award. This grant represented an important advance by GeoVax into the critical area of biodefense which we believe represents a significant growth area for the application of our technology and expertise.HIV “Cure” Program - New, Exciting Possibilities. Our collaboration with American Gene Technologies International, Inc. (AGT), for use of our vaccine in combination with AGT’s gene therapy for development of a functional cure for HIV, is on track to enter a Phase 1 trial sponsored by AGT. AGT anticipates starting the trial during the second half of 2019. We are also in discussions with two other consortiums for the possible use of our vaccine in similar efforts toward developing a cure for HIV infection. We expect that one or both of these studies may begin in late 2019 or early 2020.HIV “Prevention” Program - Continued Progress with NIH Support. In October, positive results from HVTN 114, a phase 1 trial of our preventive HIV vaccine, were presented at the HIVR4P conference in Madrid. The clinical trial program for our preventive HIV vaccine continues to be supported by the NIH and the HIV Vaccine Trials Network (HVTN), with the next study (HVTN 132) expected to commence later this year. Furthermore, during President Trump’s recent State of the Union address, he committed to pursuing the elimination of HIV within the next decade. We view our preventive vaccine developments as being critical and core to this initiative.NIH Support for ...

Houston, TX - (NewMediaWire) - March 11, 2019 - FLAME SEAL PRODUCTS, INC. (OTC PINK: FLMP), a leading provider of Specialty Chemicals for the Passive Fire Protection Market, today issues the following update to its Stockholders.From: Craig Keyser, CEOSubject: December 31, 2018 Fourth Quarter and Full Year Results and Corporate UpdateFourth Quarter and Year End Results for 2018 Flame Seal’s 2018 revenues were $2,363,122, a decrease of $135,910 or 5% less than 2017 revenues of $2,499,032, resulting in a profit of $56,196 compared to a loss of $259,325 for 2017. The profit was the result of cost reductions undertaken early in 2018. Revenues are improving but not yet satisfactory as transitions to our new technologies have required additional development time and investment in testing and certifications. While overall operations were financially constrained, the company continued to invest in key personnel, plant and equipment (PPE) and additional testing and certification. Revenues for the quarter ended December 31, 2018 were $540,019, a $74,361 increase or 16% higher than the $465,658 in 2017. Quarterly profit was $15,916 versus a $110,337 loss in 2017. Keyser said, “Our cost reductions and investments in FSP’s long term future is starting to pay off.”Craig Keyser continued, "2018 was a year of important changes and investments for Flame Seal. We successfully developed our Class A Paint for the construction industry. The marketing team is in the process of commercializing the new product for key segments of the construction industry. We have high expectations for our new product as we continue to secure new test certifications.” Homes Saved from Wild FireOn December 10, 2018, FSP issued a press release detailing how two homes in Latigo Canyon Malibu, California were saved from the massive Woolsey blaze by an installed Flame Seal FS-PG sprinkler system. Almost all other residences and outbuildings in that area were destroyed. A survivor of the fire gave a dramatic account on video of how Flame Seal’s product stopped the fire in its tracks. This FSP product is an effective, environmentally safe flame retardant that protects against wild fires. Flame Seal is formulating marketing plans to expand sales of this family of products.Online MarketingIn the fourth quarter of 2017 FSP launched its online ecommerce platform - www.flamesealshop.com. This online store allows customers to purchase most FSP products on line at any time. Sales are growing steadily, and, in time, we hope they will be significant enough to report separately.Balance Sheet UpdateAs of 12/31/2018, FSP's current ratio of assets to liabilities remained strong at 4.95. Payables are current and we have minimal receivable issues. Flame Seal has no outstanding litigation issues as of December 31, 2018.As of December 31, 2017, FSP had 71,972,696 shares outstanding, an 8,074,543 or 12.6% increase over 12/31/2017, principally attributable to debt conversion by our largest shareholder.About Flame Seal Flame Seal Products, Inc., manufacturer of the world's number one fire prevention technology, was founded in 1992 as a research and development company focused on the investigation and application of passive Fire Prevention Technologies. FLAME SEAL PRODUCTS, INC. (FLMP) began trading its common stock on March 27, 2000. Flame Seal Products, Inc. is also the Transfer Agent of record. The company offers a wide variety of Code Driven solutions for a number of diverse applications, industries, and has developed three passive fire prevention technologies which are the basis for the company's products. For more information, go to: http://flameseal.com. Financial information and news on Flame Seal is available on otcmarkets.com -- symbol FLMP -- in the "Filing and Disclosure" and “News” sections. Safe Harbor Statement Certain statements in this release may be "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to numerous risks and uncertainties. Actual results may vary significantly from the results ...